Next Article in Journal
The Outcome of Porcine Foetal Infection with Bungowannah Virus Is Dependent on the Stage of Gestation at Which Infection Occurs. Part 2: Clinical Signs and Gross Pathology
Previous Article in Journal
The RNAi Pathway Is Important to Control Mayaro Virus Infection in Aedes aegypti but not for Wolbachia-Mediated Protection
Previous Article in Special Issue
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

Special Issue “Virus-Like Particle Vaccines”

by 1,2 and 1,2,3,*
University Hospital for Rheumatology, Immunology, and Allergology, University of Bern, 3010 Bern, Switzerland
Department of BioMedical Research, University of Bern, 3010 Bern, Switzerland
Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), The Jenner Institute, University of Oxford, Oxford OX3 7BN, UK
Author to whom correspondence should be addressed.
Received: 3 August 2020 / Accepted: 4 August 2020 / Published: 10 August 2020
(This article belongs to the Special Issue Virus-Like Particle Vaccines)
Note: In lieu of an abstract, this is an excerpt from the first page.

Virus-like particles (VLPs) have become a key tool for vaccine developers and manufacturers [...] View Full-Text
MDPI and ACS Style

Vogel, M.; Bachmann, M.F. Special Issue “Virus-Like Particle Vaccines”. Viruses 2020, 12, 872.

AMA Style

Vogel M, Bachmann MF. Special Issue “Virus-Like Particle Vaccines”. Viruses. 2020; 12(8):872.

Chicago/Turabian Style

Vogel, Monique, and Martin F. Bachmann. 2020. "Special Issue “Virus-Like Particle Vaccines”" Viruses 12, no. 8: 872.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop